"Das Klinikum Stuttgart mit seinen drei Häusern Katharinenhospital, Krankenhaus Bad Cannstatt und Olgahospital bietet als Krankenhaus der Maximalversorgung umfassende medizinische Versorgung für die Menschen in Stuttgart und der Region Mittlerer Neckar. Träger der wirtschaftlich selbständigen gemeinnützigen Kommunalanstalt des öffentlichen Rechtes ist die Landeshauptstadt Stuttgart. Das Klinikum Stuttgart ist Akademisches Lehrkrankenhaus der Universität Tübingen mit direktem Zugang zu den neuesten wissenschaftlichen Erkenntnissen und Methoden in Diagnostik und Therapie."

During the past decade, Klinikum Stuttgart- Katharinenhospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Stuttgart- Katharinenhospital" #1 sponsor was "Phenox GmbH" with 3 trials, followed by "University of Ulm" with 3 trials sponsored, "Aesculap AG" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "Institut Straumann AG" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Stuttgart- Katharinenhospital" #1 collaborator was "Aesculap, Inc." with 1 trials as a collaborator, "Aktion Multiple Sklerose Erkrankter, Landesverband der DMSG in Baden-Württemberg (AMSEL) e.V." with 1 trials as a collaborator, "Central European Cooperative Oncology Group" with 1 trials as a collaborator, "German Association of Urologic Oncology" with 1 trials as a collaborator and "Groupe D'Etude des Tumeurs Uro-Genitales" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Stuttgart- Katharinenhospital" are "Intracranial Aneurysm" (3 trials), "Acute Myeloid Leukemia" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials) and "Appendicitis" (1 trials). Many other conditions were trialed in "Klinikum Stuttgart- Katharinenhospital" in a lesser frequency.

Most popular intervention types in "Klinikum Stuttgart- Katharinenhospital" are "Device" (8 trials), "Drug" (8 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (2 trials), "Best endovascular treatment or Best surgical treatment" (1 trials), "Conventional" (1 trials), "DS-Ligature Clip" (1 trials) and "Dendritic cell immunotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Stuttgart- Katharinenhospital" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Stuttgart- Katharinenhospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Klinikum Stuttgart- Katharinenhospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Stuttgart- Katharinenhospital, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".